These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 8758903

  • 1. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
    Berman DB, Costalas J, Schultz DC, Grana G, Daly M, Godwin AK.
    Cancer Res; 1996 Aug 01; 56(15):3409-14. PubMed ID: 8758903
    [Abstract] [Full Text] [Related]

  • 2. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
    Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K.
    Nat Genet; 1996 May 01; 13(1):126-8. PubMed ID: 8673092
    [Abstract] [Full Text] [Related]

  • 3. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
    Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K.
    Nat Genet; 1996 Oct 01; 14(2):188-90. PubMed ID: 8841192
    [Abstract] [Full Text] [Related]

  • 4. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
    Shiri-Sverdlov R, Oefner P, Green L, Baruch RG, Wagner T, Kruglikova A, Haitchick S, Hofstra RM, Papa MZ, Mulder I, Rizel S, Bar Sade RB, Dagan E, Abdeen Z, Goldman B, Friedman E.
    Hum Mutat; 2000 Dec 01; 16(6):491-501. PubMed ID: 11102978
    [Abstract] [Full Text] [Related]

  • 5. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
    Roa BB, Boyd AA, Volcik K, Richards CS.
    Nat Genet; 1996 Oct 01; 14(2):185-7. PubMed ID: 8841191
    [Abstract] [Full Text] [Related]

  • 6. BRCA2 germline mutations in male breast cancer cases and breast cancer families.
    Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S, Shattuck-Eidens D, Godwin AK, Daly M, Radford DM, Sedlacek S, Rommens J, Simard J, Garber J, Merajver S, Weber BL.
    Nat Genet; 1996 May 01; 13(1):123-5. PubMed ID: 8673091
    [Abstract] [Full Text] [Related]

  • 7. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.
    Clin Cancer Res; 2002 Dec 01; 8(12):3776-81. PubMed ID: 12473589
    [Abstract] [Full Text] [Related]

  • 8. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients.
    Tobias DH, Eng C, McCurdy LD, Kalir T, Mandelli J, Dottino PR, Cohen CJ.
    Gynecol Oncol; 2000 Aug 01; 78(2):148-51. PubMed ID: 10926794
    [Abstract] [Full Text] [Related]

  • 9. The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel.
    Figer A, Irmin L, Geva R, Flex D, Sulkes J, Sulkes A, Friedman E.
    Br J Cancer; 2001 Feb 01; 84(4):478-81. PubMed ID: 11207041
    [Abstract] [Full Text] [Related]

  • 10. The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds.
    Petrukhin L, Dangel J, Vanderveer L, Costalas J, Bellacosa A, Grana G, Daly M, Godwin AK.
    Cancer Res; 1997 Dec 15; 57(24):5480-4. PubMed ID: 9407954
    [Abstract] [Full Text] [Related]

  • 11. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
    Vazina A, Baniel J, Yaacobi Y, Shtriker A, Engelstein D, Leibovitz I, Zehavi M, Sidi AA, Ramon Y, Tischler T, Livne PM, Friedman E.
    Br J Cancer; 2000 Aug 15; 83(4):463-6. PubMed ID: 10945492
    [Abstract] [Full Text] [Related]

  • 12. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
    Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH, Kern SE.
    Cancer Res; 1996 Dec 01; 56(23):5360-4. PubMed ID: 8968085
    [Abstract] [Full Text] [Related]

  • 13. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M, Silva A, Rubio L, Alvarez C, Torrealba C, Salinas M, Tapia T, Faundez P, Palma L, Riccio ME, Paredes H, Rodriguez M, Cruz A, Rousseau C, King MC, Camus M, Alvarez M, Carvallo P.
    Breast Cancer Res Treat; 2006 Jan 01; 95(1):81-7. PubMed ID: 16261400
    [Abstract] [Full Text] [Related]

  • 14. Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.
    Wolf I, Laitman Y, Rubinek T, Abramovitz L, Novikov I, Beeri R, Kuro-O M, Koeffler HP, Catane R, Freedman LS, Levy-Lahad E, Karlan BY, Friedman E, Kaufman B.
    Oncogene; 2010 Jan 07; 29(1):26-33. PubMed ID: 19802015
    [Abstract] [Full Text] [Related]

  • 15. High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history.
    Beller U, Halle D, Catane R, Kaufman B, Hornreich G, Levy-Lahad E.
    Gynecol Oncol; 1997 Nov 07; 67(2):123-6. PubMed ID: 9367693
    [Abstract] [Full Text] [Related]

  • 16. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
    Tsongalis GJ, Linfert DR, Johnson RC, Ackroyd R, Berman MM, Ricci A.
    Arch Pathol Lab Med; 1998 Jun 07; 122(6):548-50. PubMed ID: 9625424
    [Abstract] [Full Text] [Related]

  • 17. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.
    Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC.
    Nat Genet; 1995 Oct 07; 11(2):198-200. PubMed ID: 7550349
    [Abstract] [Full Text] [Related]

  • 18. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
    Phelan CM, Kwan E, Jack E, Li S, Morgan C, Aubé J, Hanna D, Narod SA.
    Hum Mutat; 2002 Nov 07; 20(5):352-7. PubMed ID: 12402332
    [Abstract] [Full Text] [Related]

  • 19. Low incidence of BRCA2 mutations in breast carcinoma and other cancers.
    Teng DH, Bogden R, Mitchell J, Baumgard M, Bell R, Berry S, Davis T, Ha PC, Kehrer R, Jammulapati S, Chen Q, Offit K, Skolnick MH, Tavtigian SV, Jhanwar S, Swedlund B, Wong AK, Kamb A.
    Nat Genet; 1996 Jun 07; 13(2):241-4. PubMed ID: 8640236
    [Abstract] [Full Text] [Related]

  • 20. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL, Smith AM, Dávila MR, Sigurdson AJ, Giusti RM, Pineda MA, Doody MM, Tucker MA, Greene MH, Zhang J, Struewing JP.
    Hum Mutat; 2003 Aug 07; 22(2):121-8. PubMed ID: 12872252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.